1- Bock O., Schmid-Ott G., Malewski P. and Mrowietz U.:
Quality of life of patients with keloid and hypertrophic
scarring. Arch. Dermatol. Res., 297 (10): 435, 2006.
2- O'Sullivan S.T., O'Shaughnessy M. and O'Connor T.P.:
Aetiology and management of hypertrophic scars and
keloids. Ann. R. Coll. Surg. Engl., 78 (3 Pt 1): 168, 1996.
3- Al-Attar A., Mess S., Thomassen J.M., Kauffman C.L.
and Davison S.P.: Keloid pathogenesis and treatment.
Plast. Reconstr. Surg., 117 (1): 286-300, 2006.
Table (1): Mean VSS scores during therapy and follow-up.
VSS Time
parameter
Height
Pliability
Vascularity
Pigmentation
VSS
Week 0
2.63±0.41
3.90±0.78
2.44±0.50
2.74±0.37
11.98±1.36
Week 3
1.96±0.49
2.88±0.65
2.22±0.54
2.62±0.45
9.66±1.29
Week 6
1.18±0.62
1.88±0.79
1.7±0.54
2.40±0.49
7.18±1.75
Week 9
0.6±0.57
0.94±0.76
1.36±0.45
2.32±0.50
5.18±1.75
Month 3
0.22±0.50
0.32±0.62
1.22±0.41
2.28±0.49
4.06±1.27
p-value
<0.001
<0.001
<0.001
<0.001
<0.001
Table (2): Symptoms change in the studied cases.
Symptoms change
Improvement
Unchanged
10
3
Number of patients
Egypt, J. Plast. Reconstr. Surg., October 2019 537
4- Gauglitz G.G.: Management of keloids and hypertrophic
scars: Current and emerging options. Clin. Cosmet. Investig.
Dermatol., 6: 103, 2013.
5- Tanzi E.L. and Aister T.S.: Laser treatment of scarsadvances
in dermatologic surgery. Skin. Ther. Lett., 9 (1):
4-7, 2004.
6- Robertson J.C., Hodgson B., Druett J.E. and Druett J.:
Pressure therapy for hypertrophic scarring: Preliminary
communication. J. R. Soc. Med., 73 (5): 348-54, 1980.
7- Hatamipour E., Mehrabi S., Hatamipour M. and Shirazi
H.R.: Effects of combined intralesional 5-fluorouracil and
topical silicone in prevention of keloids: A double blind
randomized clinical trial study. Acta Med. Iran, 49 (3):
127, 2011.
8- Chrousos G.P. and Margioris A.N.: Adrenocorticosteroid
& cortico-adrenal antagonists in Katzung BG. Basic and
clinical pharmacology. 8th ed. The McGraw-Hill: United
States of America, 574-89, 2003.
9- Garg G.A., Sao P.P. and Khopkar U.S.: Effect of carbon
dioxide laser ablation followed by intralesional steroids
on keloids. J. Cutan. Aesthet. Surg., 4 (1): 2-6, 2011.
10- Elsaie M.L., Baumann L.S. and Elsaie L.T.: Striae distensae
(stretch marks) and different modalities of therapy: An
update. Dermatol. Surg., 35 (4): 563-73, 2009.
11- Gómez C., Costela A., García-Moreno I., Llanes F., Teijón
J.M. and Blanco D.: Laser treatment on skin enhancing
and controlling transdermal delivery of 5-fluorouracil.
Laser Surg. Med., 40 (1): 6-12, 2008.
12- Donelly R.F., Morrow D.I., McCarron P.A., Woolfson
A.D., Morrissey A., Juzenas P., Juzeniene A., Iani V.,
McCarthy H.O. and Moan J.: Microneedle-mediated
intradermal delivery of 5-aminolevulinic acid: Potential
for enhanced topical photodynamic therapy. J. Control
Release, 129 (3): 154-62, 2008.
13- Issa M.C.A., Kassuga L.E.B.P., Chevrand N.S. and Pires
M.T.F.: Topical delivery of triamcinolone via skin pretreated
with ablative radiofrequency: A new method in
hypertrophic scar treatment. Int. J. Dermatol., 52: 367-
70, 2012.
14- Wolfram D., Tzankov A., Pülzl P. and Piza-Katzer H.:
Hypertrophic scars and keloids-a review of their pathophysiology,
risk factors, and therapeutic management.
Transepidermal Drug Delivery: Overview, Concept and
Applications. Dermatol. Surg., 35 (2): 171-81, 2009.
15- Schwarz M. and Laaff H.A.: Prospective controlled
assessment of microneedling with the Dermaroller device.
Plast. Reconstr. Surg., 127 (6): 146e-148e, 2011.
16- Niwat P.: Percutaneous collagen induction with dermaroller
for management of atrophic acne scars in 31 Thai patients.
J. Cosmet. Dermatol., 2 (1): 1-13, 2009.
17- Baryza M.J. and Baryza G.A.: The Vancouver Scar Scale:
An administration tool and its interrater reliability. J.
Burn Care Res., 16: 535-8, 1995.
18- Haerdersdal M., Sakamoto F.H., Farinelli W.A., Doukas
A.G., Tam J. and Anderson R.R.: Fractional CO(2) laserassisted
drug delivery. Laser Surg. Med., 42 (2): 113-
22, 2010.
19- Stumpp O.F., Welch A.J., Milner T.E. and Neev J.: Enhancement
of transepidermal skin clearing agent delivery
using a 980nm diode laser. Lasers Surg. Med., 37 (4):
278-85, 2005.
20- Wang K.F., Fang J.Y., Hu C.H. and Lee W.R.: Erbium:
YAG laser pretreatment accelerates the response of Bowen's
disease treated by topical 5-fluorouracil. Dermatol.
Surg., 30 (3): 441-5, 2004.
21- Sharad J.: Combination of microneedling and glycolic
acid peels for the treatment of acne scars in dark skin. J.
Cosmet. Dermatol., 10 (4): 317-23, 2011.
22- Orentreich D.S. and Orentreich N.: Subcutaneous incisionless
(subcision) surgery for the correction of depressed
scars and wrinkles. Dermatol. Surg., 21 (6): 543-9, 1995.
23- Aust M.C., Reimers K., Repenning C., Stahl F., Jahn S.,
Guggenheim M., Schwaiger N., Gohritz A. and Vogt P.M.:
Percutaneous collagen induction: Minimally invasive skin
rejuvenation without risk of hyperpigmentation-fact or
fiction? Plast. Reconstr. Surg., 122 (5): 1553-63, 2008.
24- Patnaik V.V.G., Singla R. and Bala S.: Anatomy of 'a
beautiful face & smile'. J. Anat. Soc. India, 52 (1): 74-80
16. Sharad J. (2011) Combination of microneedling and
glycolic acid peels for the treatment of acne scars in dark
skin. J. Cosmet. Dermatol., 10 (4): 317-23, 2003
)
View on SCiNiTO